Cargando…

Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome

BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome, often with cardiohemodynamic dysfunction. Insight into mechanism of disease is still incomplete. OBJECTIVE: Our objective was to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Janice J., Gaines, Samantha B., Amezcua, Mateo L., Lubell, Tamar R., Dayan, Peter S., Dale, Marissa, Boneparth, Alexis D., Hicar, Mark D., Winchester, Robert, Gorelik, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530782/
https://www.ncbi.nlm.nih.gov/pubmed/34688775
http://dx.doi.org/10.1016/j.jaci.2021.10.015
_version_ 1784586734991835136
author Huang, Janice J.
Gaines, Samantha B.
Amezcua, Mateo L.
Lubell, Tamar R.
Dayan, Peter S.
Dale, Marissa
Boneparth, Alexis D.
Hicar, Mark D.
Winchester, Robert
Gorelik, Mark
author_facet Huang, Janice J.
Gaines, Samantha B.
Amezcua, Mateo L.
Lubell, Tamar R.
Dayan, Peter S.
Dale, Marissa
Boneparth, Alexis D.
Hicar, Mark D.
Winchester, Robert
Gorelik, Mark
author_sort Huang, Janice J.
collection PubMed
description BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome, often with cardiohemodynamic dysfunction. Insight into mechanism of disease is still incomplete. OBJECTIVE: Our objective was to analyze immunologic features of MIS-C patients compared to febrile controls (FC). METHODS: MIS-C patients were defined by narrow criteria, including having evidence of cardiohemodynamic involvement and no macrophage activation syndrome. Samples were collected from 8 completely treatment-naive patients with MIS-C (SARS-CoV-2 serology positive), 3 patients with unclassified MIS-C–like disease (serology negative), 14 FC, and 5 MIS-C recovery (RCV). Three healthy controls (HCs) were used for comparisons of normal range. Using spectral flow cytometry, we assessed 36 parameters in antigen-presenting cells (APCs) and 29 in T cells. We used biaxial analysis and uniform manifold approximation and projection (UMAP). RESULTS: Significant elevations in cytokines including CXCL9, M-CSF, and IL-27 were found in MIS-C compared to FC. Classic monocytes and type 2 dendritic cells (DCs) were downregulated (decreased CD86, HLA-DR) versus HCs; however, type 1 DCs (CD11c(+)CD141(+)CLEC9A(+)) were highly activated in MIS-C patients versus FC, expressing higher levels of CD86, CD275, and atypical conventional DC markers such as CD64, CD115, and CX3CR1. CD169 and CD38 were upregulated in multiple monocyte subtypes. CD56(dim)/CD57(−)/KLRG(hi)/CD161(+)/CD38(−) natural killer (NK) cells were a unique subset in MIS-C versus FC without macrophage activation syndrome. CONCLUSION: Orchestrated by complex cytokine signaling, type 1 DC activation and NK dysregulation are key features in the pathophysiology of MIS-C. NK cell findings may suggest a relationship with macrophage activation syndrome, while type 1 DC upregulation implies a role for antigen cross-presentation.
format Online
Article
Text
id pubmed-8530782
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-85307822021-10-22 Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome Huang, Janice J. Gaines, Samantha B. Amezcua, Mateo L. Lubell, Tamar R. Dayan, Peter S. Dale, Marissa Boneparth, Alexis D. Hicar, Mark D. Winchester, Robert Gorelik, Mark J Allergy Clin Immunol Covid-19 BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome, often with cardiohemodynamic dysfunction. Insight into mechanism of disease is still incomplete. OBJECTIVE: Our objective was to analyze immunologic features of MIS-C patients compared to febrile controls (FC). METHODS: MIS-C patients were defined by narrow criteria, including having evidence of cardiohemodynamic involvement and no macrophage activation syndrome. Samples were collected from 8 completely treatment-naive patients with MIS-C (SARS-CoV-2 serology positive), 3 patients with unclassified MIS-C–like disease (serology negative), 14 FC, and 5 MIS-C recovery (RCV). Three healthy controls (HCs) were used for comparisons of normal range. Using spectral flow cytometry, we assessed 36 parameters in antigen-presenting cells (APCs) and 29 in T cells. We used biaxial analysis and uniform manifold approximation and projection (UMAP). RESULTS: Significant elevations in cytokines including CXCL9, M-CSF, and IL-27 were found in MIS-C compared to FC. Classic monocytes and type 2 dendritic cells (DCs) were downregulated (decreased CD86, HLA-DR) versus HCs; however, type 1 DCs (CD11c(+)CD141(+)CLEC9A(+)) were highly activated in MIS-C patients versus FC, expressing higher levels of CD86, CD275, and atypical conventional DC markers such as CD64, CD115, and CX3CR1. CD169 and CD38 were upregulated in multiple monocyte subtypes. CD56(dim)/CD57(−)/KLRG(hi)/CD161(+)/CD38(−) natural killer (NK) cells were a unique subset in MIS-C versus FC without macrophage activation syndrome. CONCLUSION: Orchestrated by complex cytokine signaling, type 1 DC activation and NK dysregulation are key features in the pathophysiology of MIS-C. NK cell findings may suggest a relationship with macrophage activation syndrome, while type 1 DC upregulation implies a role for antigen cross-presentation. American Academy of Allergy, Asthma & Immunology 2022-03 2021-10-22 /pmc/articles/PMC8530782/ /pubmed/34688775 http://dx.doi.org/10.1016/j.jaci.2021.10.015 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19
Huang, Janice J.
Gaines, Samantha B.
Amezcua, Mateo L.
Lubell, Tamar R.
Dayan, Peter S.
Dale, Marissa
Boneparth, Alexis D.
Hicar, Mark D.
Winchester, Robert
Gorelik, Mark
Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome
title Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome
title_full Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome
title_fullStr Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome
title_full_unstemmed Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome
title_short Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome
title_sort upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530782/
https://www.ncbi.nlm.nih.gov/pubmed/34688775
http://dx.doi.org/10.1016/j.jaci.2021.10.015
work_keys_str_mv AT huangjanicej upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT gainessamanthab upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT amezcuamateol upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT lubelltamarr upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT dayanpeters upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT dalemarissa upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT boneparthalexisd upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT hicarmarkd upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT winchesterrobert upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome
AT gorelikmark upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome